IP Library Granted Patent US 8,304,233
Granted Patent B2
US 8,304,233 · App. 11/198,885 · Granted Nov 6, 2012

Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same

Assignees: Poetic Genetics, LLC; The Board of Trustees of the Leland Stanford Junior University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,304,233
App. No.
11/198,885
Granted
Nov 6, 2012
Kind
B2
Abstract

The subject invention provides a unidirectional site-specific integration system for integrating a nucleic acid into the genome of a target cell. The provided system includes a site-specific integrating expression cassette (INTEC) vector, consisting of (a) a polynucleotide of interest operably linked to a promoter, (b) a single recombination site, and (c) a hybrid recombination site. In using the subject systems for site-specific integration, the INTEC vector and integrase are introduced into the target cell and the cell is maintained under conditions sufficient to provide for site-specific integration of the nucleic acid into the target cell genome via a recombination event mediated by the site-specific recombinase. Also provided are kits that include the subject systems. The subjects systems, methods and kits find use in a variety of different applications, several representative ones of which are described in detail as well.

Claims (8)

1. A site-specific integrating expression cassette (INTEC) vector, wherein the INTEC vector consists of:

(a) a polynucleotide of interest operably linked to a promoter,

(b) a single recombination site selected from an attP site, an attB site, a pseudo attP site, and a pseudo attB site that is a substrate for recombination by a unidirectional site-specific recombinase selected from a φC31 phage recombinase, a TP901-1 phage recombinase, or an R4 phage recombinase, wherein said single recombination site is a substrate for recombination with a recombination site in the genome of a target cell by said unidirectional site-specific recombinase, and

(c) a hybrid recombination site selected from an attL site and an attR site, wherein the hybrid recombination site is not a substrate for said unidirectional site-specific recombinase.

2. The INTEC vector of claim 1 , wherein said single recombination site is an attP site or an attB site.

3. The INTEC vector of claim 1 , wherein said single recombination site is a pseudo attP site or a pseudo attB site.

4. The INTEC vector of claim 1 , wherein said unidirectional site-specific recombinase is φC31 phage recombinase.

5. The INTEC vector of claim 1 , wherein said polynucleotide of interest comprises a coding sequence.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 12, 2013
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030792/0524 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2005
From: CALOS, MICHELE P.
To: POETIC GENETICS, LLC; THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 016903/0183 →
Continuity (12)
Continuation In Part 11003941 · Dec 3, 2004
Continuation PCTUS0317702 · Jun 3, 2003
Provisional Application 60599687 · Aug 6, 2004
Provisional Application 60385954 · Jun 4, 2002
Provisional Application 60385933 · Jun 4, 2002
Provisional Application 60386325 · Jun 4, 2002
Provisional Application 60385934 · Jun 4, 2002
Provisional Application 60385929 · Jun 4, 2002
Provisional Application 60386597 · Jun 4, 2002
Provisional Application 60385944 · Jun 4, 2002
Provisional Application 60416989 · Oct 7, 2002
Related Publication 20060128020A1 · Jun 15, 2006